Clinical trial
Flurbiprofen Axetil as an Adjuvant to Pre-emptive Scalp Infiltration for Post-craniotomy Pain
NCT05624359 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Flurbiprofen Axetil as an Adjuvant to Pre-emptive Scalp Infiltration for Post-craniotomy Pain
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- November 1, 2023
- Completion date
- March 1, 2026
- Enrollment
- 216 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.